首页|胺碘酮联合琥珀酸美托洛尔缓释片治疗急性室性心律失常的效果及对心功能稳定状况的影响研究

胺碘酮联合琥珀酸美托洛尔缓释片治疗急性室性心律失常的效果及对心功能稳定状况的影响研究

扫码查看
目的 研究胺碘酮联合琥珀酸美托洛尔缓释片治疗急性室性心律失常的效果及对心功能稳定状况的影响。方法 选取 60 例急性室性心律失常患者作为研究对象,按照随机抽签法分为观察组(n=30)和对照组(n=30)。两组均采取常规治疗,在此基础上对照组采取琥珀酸美托洛尔缓释片治疗,观察组采取琥珀酸美托洛尔缓释片联合胺碘酮治疗。对比两组的临床疗效、心功能指标[左心室舒张末期内径(LVEDD)、左心室射血分数(LVEF)和左心室收缩末期内径(LVESD)]、心率和PR间期。结果 观察组临床总有效率 96。67%高于对照组的 76。67%(P<0。05)。治疗前两组LVEDD、LVEF、LVESD比较无差异(P>0。05);治疗后,两组LVEF大于治疗前,LVEDD、LVESD均小于治疗前,且观察组LVEF(53。05±3。45)%大于对照组的(45。11±3。29)%,LVEDD(47。08±3。46)mm、LVESD(36。19±2。71)mm均小于对照组的(54。18±3。52)、(40。95±2。60)mm(P<0。05)。治疗前,两组心率和PR间期比较无差异(P>0。05);相较于治疗前,治疗后两组心率下降,PR间期升高,且观察组治疗后心率和PR间期均优于对照组(P<0。05)。结论 在急性室性心律失常的临床治疗中,与单纯琥珀酸美托洛尔缓释片治疗相比较,联合胺碘酮治疗能够有效提升临床疗效,改善患者的心功能,促进心率恢复,对心功能稳定有着积极作用。
Study on effect of amiodarone combined with metoprolol succinate sustained-release tablets in the treatment of acute ventricular arrhythmia and its influence on stability of cardiac function
Objective To study the effect of amiodarone combined with metoprolol succinate sustained-release tablets in the treatment of acute ventricular arrhythmia and its influence on stability of cardiac function.Methods 60 patients with acute ventricular arrhythmia were selected as the study subjects and divided into an observation group(n=30)and a control group(n=30)according to random lottery method.Both groups received conventional treatment,on the basis of which the control group was treated with metoprolol succinate sustained-release tablets,and the observation group was treated with metoprolol succinate sustained-release tablets and amiodarone.Comparison was made on clinical efficacy,cardiac function indexes[left ventricular end-diastolic diameter(LVEDD),left ventricular ejection fraction(LVEF)and left ventricular end-systolic diameter(LVESD)],heart rate and PR interval between the two groups.Results The total clinical effective rate of the observation group was 96.67%,which was higher than the control group's 76.67%(P<0.05).Before treatment,there was no difference between the two groups in terms of LVEDD,LVEF and LVESD(P>0.05).After treatment,LVEF in both groups was higher than that before treatment,and LVEDD and LVESD were lower than those before treatment;the observation group had higher LVEF of(53.05±3.45)%than(45.11±3.29)%in the control group;the observation group had LVEDD of(47.08±3.46)mm and LVESD of(36.19±2.71)mm,which were smaller than(54.18±3.52)and(40.95±2.60)mm in the control group(P<0.05).Before treatment,there were no differences in heart rate and PR interval between the two groups(P>0.05).Compared with before treatment,the heart rate decreased and PR interval increased in the two groups after treatment,and both heart rate and PR interval in the observation group were better than those in the control group after treatment(P<0.05).Conclusion In the clinical treatment of acute ventricular arrhythmia,compared with the treatment of metoprolol succinate sustained-release tablets alone,combined treatment with amiodarone can effectively improve the clinical efficacy,improve the cardiac function of patients,promote the recovery of heart rate,and have a positive effect on the stability of cardiac function.

AmiodaroneMetoprolol succinate sustained-release tabletsVentricular arrhythmiaCardiac function

田光辉、宋向成

展开 >

435300 湖北省蕲春县人民医院

胺碘酮 琥珀酸美托洛尔缓释片 室性心律失常 心功能

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(9)